This Week in PLOS

A number of microRNAs can repress translation of Twist1, a proto-oncogene whose upregulation is linked to resistance to cancer drugs, report Aarhus University researchers in PLOS One. In a number of cell lines, the researchers found that miR-145a-5p, miR-151-5p and a combination of miR-145a-5p and miR-151-5p or of miR-151-5p and miR-337-3p could repress the expression of the oncogene.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in PLOS

This Week in PLOS

This Week in PLOS

This Week in Cell

This Week in PLOS

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.